News, Calendar, Documents

Clear. Timely. Compliant.

Stay informed with our market-relevant disclosures in line with capital market regulations, including Article 17 MAR.

Business meeting handshake in bright office with financial charts and pen on reflective table, representing corporate transparency and compliance

Financial Publications

Full Year - Consolidated Financial Statements

Planned

March 2027

Q3 Trading Update

Planned

November 2026

Half Year - Interim Consolidated Financial Statements

Planned

August 2026

Q1 - Earnings (presentation)

Published

May 26, 2026

Q1 - Interim Consolidated Financial Statements

Published

May 26, 2026

Financial Calendar

Event

Status

Location

Date

Berenberg/Goldman Sachs German Corporate Conference

Upcoming Event

Munich

Sep 23, 2026

Deutsche Börse Scale Summit

Upcoming Event

Online

Jun 23 – 24, 2026

Annual General Meeting 2026

Past Event

Online

Apr 21, 2026

Berenberg EU Opportunities Conference

Past Event

London

Mar 05, 2026

Investor Call – Preliminary Annual Results for 2025

Past Event

Online

Feb 03, 2026

Berenberg European Conference

Past Event

London

Dec 01, 2025

Deutsches Eigenkapitalforum 2025

Past Event

Frankfurt a. M.

Nov 26, 2025

Berenberg US Discovery Conference

Past Event

Online

Nov 12 – 13, 2025

40. Münchner Kapitalmarkt Konferenz

Past Event

Munich

Nov 13, 2025

Berenberg/Goldman Sachs German Corporate Conference

Past Event

Munich

Sep 22, 2025

Ad-hoc News

date

news title

Feb 25, 2026

innoscripta SE publishes Guidance for 2026

Feb 20, 2026

innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

Jan 27, 2026

innoscripta SE: Preliminary Annual Results for 2025

May 21, 2025

innoscripta SE sets final price for IPO at EUR 120.00 per share

News

Date

News Title

Apr 15, 2026

innoscripta drives expansion in Europe: Market entry in France completed

Mar 19, 2026

innoscripta SE Expands into the Rhine-Main Growth Region and Strengthens Its Positioning as a Leading R&D Platform Provider with a New Office in Frankfurt

Mar 04, 2026

innoscripta SE leads listed German companies in the Financial Times/Statista ranking

Jan 27, 2026

innoscripta SE publishes Preliminary Annual Results for 2025

Nov 03, 2025

innoscripta reports successful third quarter of 2025

Oct 29, 2025

innoscripta SE announces publication of Q3 figures for 2025

Aug 21, 2025

innoscripta reports successful first half of 2025

Aug 06, 2025

innoscripta SE announces publication of half-year figures for 2025

Jun 17, 2025

innoscripta SE: Founders Plan Selective Share Purchases to Support Share Price

Jun 10, 2025

innoscripta SE: Cabinet draft provides for 20% flat-rate surcharge and increased funding cap for R&D tax incentive starting in 2026